Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial nephrectomy for renal tumour: 21 cases

A Puigvert

    European Urology
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Partial nephrectomy is a viable kidney tumor treatment for well-limited tumors, especially in solitary kidney patients. This approach is not recommended for urothelial tumors, offering a valuable alternative to radical surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hydronephrosis.

    Revista medica dominicana·2014
    Same author

    The fiftieth anniversary of cystoscopic catheterization of the ureters with Albarran's deflector (1897-1947).

    The Urologic and cutaneous review·2010
    Same author

    Clinical experience with apomorphine hydrochloride: the first 107 patients.

    The Journal of urology·2003
    Same author

    Partial nephrectomy for tumour.

    International urology and nephrology·1989
    Same author

    [The clinical history].

    Archivos espanoles de urologia·1986
    Same author

    [Medullary polycystosis of the kidney].

    Archivos espanoles de urologia·1986
    Same journal

    Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

    European urology·2026
    Same journal

    Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

    European urology·2026
    Same journal

    Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

    European urology·2026
    Same journal

    In Memory of Paul Mitrofanoff (1934-2025).

    European urology·2026
    Same journal

    Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

    European urology·2026
    Same journal

    Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

    European urology·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Urologic Oncology
    • Surgical Oncology

    Background:

    • Partial nephrectomy (PN) is a surgical option for kidney tumors.
    • Radical nephrectomy (RN) is a traditional treatment for kidney cancer.
    • Long-term data comparing PN and RN is crucial for treatment guidelines.

    Observation:

    • Twenty-one cases of kidney tumors treated with partial nephrectomy were analyzed.
    • The study compared outcomes with historical data from radical surgery over 46 years.
    • Tumor characteristics and patient status (e.g., solitary kidney) influenced treatment decisions.

    Findings:

    • Partial nephrectomy is suitable for well-circumscribed parenchymal kidney tumors.
    • PN is obligatory for patients with a solitary kidney and kidney tumors.

    Related Experiment Videos

  • PN is not recommended for tumors originating from the urothelium.

    • Implications:

    • Encourages the judicious use of partial nephrectomy for kidney tumors, particularly in solitary kidney patients.
    • Highlights the importance of patient-specific factors in choosing between partial and radical nephrectomy.
    • Supports PN as a valuable organ-sparing alternative to radical surgery in select cases.